Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry

被引:0
|
作者
Sack, Coralynn [1 ]
Wojdyla, Daniel M. [2 ]
Macmurdo, Maeve G. [3 ]
Gassett, Amanda [1 ]
Kaufman, Joel D. [1 ]
Raghu, Ganesh [1 ]
Redlich, Carrie A. [4 ]
Li, Peide [5 ]
Olson, Amy L. [5 ]
Leonard, Thomas B. [5 ]
Todd, Jamie L. [2 ,6 ]
Neely, Megan L. [2 ,6 ]
Snyder, Laurie D. [2 ,6 ]
Gulati, Mridu [4 ]
机构
[1] Univ Washington, 303 Roosevelt One Bldg,4225 Roosevelt Way NE, Seattle, WA 98105 USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Cleveland Clin, Cleveland, OH USA
[4] Yale Sch Med, New Haven, CT USA
[5] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[6] Duke Univ, Med Ctr, Durham, NC USA
关键词
interstitial lung diseases; pulmonary fibrosis; pollution; ACUTE EXACERBATION; ASSOCIATION; DIAGNOSIS; SURVIVAL;
D O I
10.1513/AnnalsATS.202404-382OC
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: Although exposure to air pollution is a known risk factor for adverse pulmonary outcomes, its impact in individuals with idiopathic pulmonary fibrosis (IPF) is less well understood. Objectives: To investigate the effects of long-term exposure to air pollution on disease severity and progression in patients with IPF and to determine whether genomic factors, such as MUC5B promoter polymorphism or telomere length, modify these associations. Methods: We performed analyses at enrollment and after 1 year of follow-up in the IPF-PRO (Idiopathic Pulmonary Fibrosis Prospective Outcomes) Registry, a prospective observational registry that enrolled individuals with IPF at 46 U.S. sites from June 2014 to October 2018. Five-year average pollution exposures (particulate matter <= 2.5 mu m in aerodynamic diameter [PM2.5], nitrogen dioxide, ozone) before the enrollment date were estimated at participants' residential addresses with validated national spatiotemporal models. Multivariable regression models estimated associations between pollution exposure and physiologic measurements (forced vital capacity [FVC], diffusing capacity of the lung for carbon monoxide, supplemental oxygen use at rest) and quality-of-life measurements (St. George's Respiratory Questionnaire, EuroQoL, Cough and Sputum Assessment Questionnaire) at enrollment. Cox proportional hazards models estimated associations between pollutants and a composite outcome of death, lung transplant, or >10% absolute decline in FVC percent predicted in the year after enrollment. Models were adjusted for individual-level and spatial confounders, including proxies for disease onset. Gene-environment interactions with MUC5B and telomere length were assessed. Results: Of 835 participants, 94% were non-Hispanic White individuals, 76% were male, and the mean (standard deviation) age was 70 (7.7) years. In fully adjusted analyses, higher PM2.5 exposure was associated with worse quality of life per St. George's Respiratory Questionnaire activity score (3.48 [95% confidence interval (CI), 0.64, 6.32] per 2 mu g/m(3) PM2.5) and EuroQoL scores (-0.04 [95% CI, -0.06, -0.01] per 2 mu g/m(3) PM2.5), as well as lower FVC percent predicted and lower diffusing capacity of the lung for carbon monoxide percent predicted at enrollment(.) Each 3 parts per billion difference in O-3 exposure was associated with a 1.57% (95% CI, 0.15, 2.98) higher FVC percent predicted at enrollment, although this effect was attenuated in multipollutant models. There was no association between nitrogen dioxide and enrollment measures or between pollution exposure and 1-year outcomes and no evidence for gene-environment interactions. Conclusions: In the IPF-PRO Registry, long-term exposure to PM2.5 was associated with worse quality of life and lung function at enrollment, but not with short-term disease progression or mortality. There was no evidence of effect modification by interaction of genomic factors with pollution. The reason for the unexpected relationship between O-3 exposure and higher FVC is unclear.
引用
收藏
页码:378 / 386
页数:9
相关论文
共 50 条
  • [31] Prevalence Of Pulmonary Hypertension In Newly Diagnosed Patients With Idiopathic Pulmonary Fibrosis (ipf) Enrolled In The Ipf-Pro Registry
    Sheth, J. S.
    Belloli, E.
    Salisbury, M.
    Holtze, C. H.
    Yow, E.
    Neely, M. L.
    Conoscenti, C. S.
    White, E. S.
    Flaherty, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [32] Association of Genetic Variants with Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Data from the IPF-PRO Registry
    Todd, J. L.
    Povysil, G.
    Allen, A. S.
    Dilling, D. F.
    Kim, H. J.
    Neely, M. L.
    Noth, I.
    Ren, Z.
    Snyder, L. D.
    Strek, M. E.
    Swaminathan, A.
    Zhang, D.
    Hesslinger, C.
    Leonard, T. B.
    Goldstein, D. B.
    Palmer, S. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [33] HEALTH-RELATED QUALITY OF LIFE MEASURES IN IDIOPATHIC PULMONARY FIBROSIS: DATA FROM THE IPF-PRO REGISTRY
    Swaminathan, Aparna
    O'Brien, Emily
    Hellkamp, Anne
    Neely, Megan
    Bender, Shaun
    Snyder, Laurie
    Culver, Daniel
    Conoscenti, Craig
    Todd, Jamie
    Palmer, Scott
    Leonard, Thomas
    CHEST, 2019, 156 (04) : 180A - 181A
  • [34] Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
    Joao A. de Andrade
    Tejaswini Kulkarni
    Megan L. Neely
    Anne S. Hellkamp
    Amy Hajari Case
    Daniel A. Culver
    Kalpalatha Guntupalli
    Shaun Bender
    Craig S. Conoscenti
    Laurie D. Snyder
    Respiratory Research, 23
  • [35] Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
    de Andrade, Joao A.
    Kulkarni, Tejaswini
    Neely, Megan L.
    Hellkamp, Anne S.
    Case, Amy Hajari
    Culver, Daniel A.
    Guntupalli, Kalpalatha
    Bender, Shaun
    Conoscenti, Craig S.
    Snyder, Laurie D.
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [36] Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
    Jamie L. Todd
    Megan L. Neely
    Robert Overton
    Katey Durham
    Mridu Gulati
    Howard Huang
    Jesse Roman
    L. Kristin Newby
    Kevin R. Flaherty
    Richard Vinisko
    Yi Liu
    Janine Roy
    Ramona Schmid
    Benjamin Strobel
    Christian Hesslinger
    Thomas B. Leonard
    Imre Noth
    John A. Belperio
    Scott M. Palmer
    Respiratory Research, 20
  • [37] Description Of Diagnostic Processes Undertaken For Patients With Idiopathic Pulmonary Fibrosis Enrolled In The Ipf-Pro Registry
    Holtze, C. H.
    Salisbury, M.
    Sheth, J. S.
    Belloli, E.
    White, E. S.
    Neely, M. L.
    Yow, E.
    Gamerman, V.
    Flaherty, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [38] Exploring Relationships Between Resources and Practices of ILD Centers and Outcomes in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry
    De Andrade, J. A.
    Kulkarni, T.
    Neely, M. L.
    Hellkamp, A. S.
    Case, A. Hajari
    Culver, D. A.
    Guntupalli, K.
    Bender, S.
    Conoscenti, C. S.
    Snyder, L. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [39] Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
    Todd, Jamie L.
    Neely, Megan L.
    Overton, Robert
    Durham, Katey
    Gulati, Mridu
    Huang, Howard
    Roman, Jesse
    Newby, L. Kristin
    Flaherty, Kevin R.
    Vinisko, Richard
    Liu, Yi
    Roy, Janine
    Schmid, Ramona
    Strobel, Benjamin
    Hesslinger, Christian
    Leonard, Thomas B.
    Noth, Imre
    Belperio, John A.
    Palmer, Scott M.
    Asi, Wael
    Baker, Albert
    Beegle, Scott
    Belperio, John A.
    Condos, Rany
    Cordova, Francis
    Culver, Daniel A.
    de Andrade, Joao A. M.
    Dilling, Daniel
    Flaherty, Kevin R.
    Glassberg, Marilyn
    Gulati, Mridu
    Guntupalli, Kalpalatha
    Gupta, Nishant
    Case, Amy Hajari
    Hotchkin, David
    Huie, Tristan
    Kaner, Robert
    Kim, Hyun
    Kreider, Maryl
    Lancaster, Lisa
    Lasky, Joseph
    Lederer, David
    Lee, Doug
    Liesching, Timothy
    Lipchik, Randolph
    Lobo, Jason
    Mageto, Yolanda
    Menon, Prema
    Morrison, Lake
    Namen, Andrew
    RESPIRATORY RESEARCH, 2019, 20 (01)
  • [40] Circulating Urokinase-Type Plasminogen Activator Receptor Protein Highly Correlates With the Severity of Idiopathic Pulmonary Fibrosis (IPF): Data From the IPF-PRO Registry
    Todd, J. L.
    Mulder, H.
    Neely, M. L.
    Belperio, J. A.
    Lasky, J. A.
    Luckhardt, T. R.
    Palmer, S. M.
    Hesslinger, C.
    Schlange, T.
    Leonard, T. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207